Funded Tech Companies
Neurogene
Headquartered in New York, Neurogene has funding from Alexandria Venture Investments, BlackRock and Avidity Partners.
Company Overview
Company Name
Neurogene
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
535 W 24th St. 5th Floor
New York, NY 10011
USA
New York, NY 10011
USA
Phone
Website
Email Address
Company Background Information
Overview
Neurogene is accelerating development of new genetic medicines to people with devastating neurological diseases and their families. To do this, we are working with experts across the globe to advance a broad pipeline of programs to treat the underlying cause of serious neurological disorders and thereby address the overwhelming need for new therapies.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
12/17/2020
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Rachel McMinn
Chief Medical Officer
Effie Albanis
Chief Scientific Officer
Stuart Cobb
President
Christine Mikail
VP - Operations
Ricardo Jimenez
VP - Operations
Arvind Sreedharan
Company Investors
- Alexandria Venture Investments
- BlackRock
- Avidity Partners
- Ascendant BioCapital
- EcoR1 Capital Management (Oleg Nodelman)
- Samsara BioCapital
- Casdin Capital
- Cormorant Asset Management
- Redmile Group
- Janus Henderson Investors
- ArrowMark Partners
Browse more funded tech companies:
Neurogastrx | NeuroGenetic Pharmaceuticals
Share this article
About Our Venture Capital Database
Our data comes from VentureDeal.com, a leading supplier of venture capital funding data.
Additional Resources for Entrepreneurs